Literature for Cpp-Ala-Ala-Phe-pAb (M03.001 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2020
1. Dalio,F.M., Machado,M.F.M., Marcondes,M.F., Juliano,M.A., Chagas,J.R., Cunha,R.L.O.R. and Oliveira,V.
   CPP-Ala-Ala-Tyr-PABA inhibitor analogs with improved selectivity for neurolysin or thimet oligopeptidase
   Biochem Biophys Res Commun522, 368-373. PubMed  Europe PubMed DOI  I
2002
2. [YEAR:3-9-2002]Steer,D., Lew,R., Perlmutter,P., Smith,A.I. and Aguilar,M.I.
   Inhibitors of metalloendopeptidase EC 3.4.24.15 and EC 3.4.24.16 stabilized against proteolysis by the incorporation of beta-amino acids
   Biochemistry41, 10819-10826. PubMed  Europe PubMed DOI  I
2000
3. [YEAR:15-1-2000]Shrimpton,C.N., Abbenante,G., Lew,R.A. and Smith,I.
   Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15
   Biochem J345, 351-356. PubMed  Europe PubMed DOI  I
1996
4. Lew,R.A., Tomoda,F., Evans,R.G., Lakat,L., Boublik,J.H., Pipolo,L.A. and Smith,A.I.
   Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo
   Br J Pharmacol118, 1269-1277. PubMed  Europe PubMed  I
1984
5. [YEAR:31-7-1984]Chu,T.G. and Orlowski,M.
   Active site directed N-carboxymethyl peptide inhibitors of a soluble metalloendopeptidase from rat brain
   Biochemistry23, 3598-3603. PubMed  Europe PubMed  I